Not Yet a Biotech Empire

In the pipelineNumber of drugs in development by New York companiesEmploymentNumber of biotechnology employees in New York††Includes only those companies still in existence or operating in the state in 2002Facts and figures• New York is home to 101 biotechnology companies, more than half of which focus on the development of new therapeutic products and related drug-delivery technologies• For every public biotech company in New York state, there are about three private one

Written byFrancesco Fiondella

| 1 min read

Save for Later

Listen with Speechify

0:00

1:00

Number of drugs in development by New York companies

Number of biotechnology employees in New York^†

^†Includes only those companies still in existence or operating in the state in 2002

• New York is home to 101 biotechnology companies, more than half of which focus on the development of new therapeutic products and related drug-delivery technologies

• For every public biotech company in New York state, there are about three private ones

• The public companies within this group have a combined market capitalization of approximately $8.6 billion

Source: New York Biotechnology Assoc., "2004 State of the Industry Report"

- Francesco Fiondella

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!

Join for free today

Already a member?